FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Anderman Sigmund 		2. Issuer Name and Ticker or Trading Symbol

ELLIE MAE INC [ ELLI ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

C/O ELLIE MAE, INC., 4420 ROSEWOOD DRIVE, SUITE 500 		3. Date of Earliest Transaction (MM/DD/YYYY)

4/17/2019
(Street)

PLEASANTON, CA 94588
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   4/17/2019     D    7117   (1) D $99.0   0   D    
Common Stock   4/17/2019     D    40000   (2) D $99.0   0   I   Anderman Fy Fndtn   (3)
Common Stock   4/17/2019     D    10000   (2) D $99.0   0   I   by 401(k) Plan  
Common Stock   4/17/2019     D    28906   (2) D $99.0   0   I   by Trust  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy)   $5.02   4/17/2019     D         18081      (4) 8/17/2021   Common Stock   18081   $99.0   0   D    
Non-Qualified Stock Option (right to buy)   $8.85   4/17/2019     D         230      (4) 8/26/2020   Common Stock   230   $99.0   0   D    
Non-Qualified Stock Option (right to buy)   $8.85   4/17/2019     D         2605      (4) 9/16/2020   Common Stock   2605   $99.0   0   D    
Non-Qualified Stock Option (right to buy)   $19.6   4/17/2019     D         50000      (4) 2/4/2023   Common Stock   50000   $99.0   0   D    
Non-Qualified Stock Option (right to buy)   $24.93   4/17/2019     D         50000      (4) 2/5/2024   Common Stock   50000   $99.0   0   D    
Non-Qualified Stock Option (right to buy)   $40.32   4/17/2019     D         76648      (4) 12/31/2024   Common Stock   76648   $99.0   0   D    
Non-Qualified Stock Option (right to buy)   $40.33   4/17/2019     D         71648      (4) 1/5/2025   Common Stock   71648   $99.0   0   D    
Non-Qualified Stock Option (right to buy)   $59.78   4/17/2019     D         14506      (4) 2/10/2026   Common Stock   14506   $99.0   0   D    
Non-Qualified Stock Option (right to buy)   $73.11   4/17/2019     D         5082      (4) 1/18/2029   Common Stock   5082   $99.0   0   D    
Non-Qualified Stock Option (right to buy)   $92.28   4/17/2019     D         4641      (4) 2/21/2028   Common Stock   4641   $99.0   0   D    
Non-Qualified Stock Option (right to buy)   $94.66   4/17/2019     D         6601      (4) 2/15/2027   Common Stock   6601   $99.0   0   D    

Explanation of Responses:
(1)  Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award that was still subject to performance-based vesting became vested with respect to a number of shares subject to such award calculated in accordance with the award's existing terms and all outstanding restricted unit award was cancelled and converted into the right to receive $99.00 in cash in respect of each vested share subject to such award.
(2)  Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated February 11, 2019, by and among Ellie Mae, Inc., a Delaware corporation ("Issuer"), EM Eagle Purchaser, LLC, a Delaware limited liability company ("Parent") and EM Eagle Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), on April 17, 2019, Merger Sub merged with and into Issuer (the "Merger"), with Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger ("Effective Time") each share of Common Stock was cancelled and converted into the right to receive $99.00 in cash, without interest.
(3)  Shares held in Anderman Family Foundation.
(4)  Pursuant to the Merger Agreement, at the Effective Time, each stock option, whether vested or unvested, was cancelled and automatically converted into the right to receive a cash amount equal to (i) the aggregate number of shares subject to such option multiplied by (ii) $99.00 less the applicable per share exercise price under such option.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Anderman Sigmund
C/O ELLIE MAE, INC.
4420 ROSEWOOD DRIVE, SUITE 500
PLEASANTON, CA 94588 		X



Signatures
/s/ Sigmund Anderman 4/17/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Ellie Mae, Inc. (NYSE:ELLI)
過去 株価チャート
から 11 2024 まで 12 2024 Ellie Mae, Inc.のチャートをもっと見るにはこちらをクリック
Ellie Mae, Inc. (NYSE:ELLI)
過去 株価チャート
から 12 2023 まで 12 2024 Ellie Mae, Inc.のチャートをもっと見るにはこちらをクリック